Sun, Apr 20, 2014, 10:25 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

R.R. Donnelley & Sons Company Message Board

jaketristen 6 posts  |  Last Activity: Apr 15, 2014 4:09 PM Member since: Jun 14, 2010
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Late Model Results - FYI

    by mikerconfer Apr 15, 2014 12:23 AM
    jaketristen jaketristen Apr 15, 2014 4:09 PM Flag

    That was funny. Some individuals can't hide being stupid or judgemental. They cannot take responsibility for their actions. Always appreciate your insight. I have never known it to be a bad thing to get multiple opinions especially when they have merit. thanks for your posts.

  • Reply to

    Late Model Results - FYI

    by mikerconfer Apr 15, 2014 12:23 AM
    jaketristen jaketristen Apr 15, 2014 3:21 PM Flag

    Thank you. Hope you let us know when you decide to buy back in. Like your timing and analysis and it is always good to get as many opinions as possible.

  • Reply to

    Late Model Results - FYI

    by mikerconfer Apr 15, 2014 12:23 AM
    jaketristen jaketristen Apr 15, 2014 3:03 PM Flag

    Hello mike like you posts. I was wondering what your re entry point is on HZNP is if you have one. Are waiting until after earnings or for a particular price or any other analysis that you are using?

  • jaketristen jaketristen Apr 11, 2014 1:29 PM Flag

    Maybe you have heard of these companies and drugs below that TW managed to make money for. Maybe not but you need to do a little research or just read.

    From 2001 to 2005, Mr. Walbert served as divisional vice president and general manager, immunology, where he led the global development and launch of the multi-indication biologic HUMIRA, which is on track to exceed $10.0 billion in 2013 sales, and divisional vice president, global cardiovascular strategy at Abbott, now AbbVie. From 1998 to 2001, Mr. Walbert served as director, CELEBREX North America and arthritis team leader, Asia Pacific, Latin America and Canada at G.D. Searle & Company. From 1991 to 1998, Mr. Walbert also held sales and marketing roles with increasing responsibility at G.D. Searle, Merck & Co., Inc. and Wyeth.

  • Reply to

    Apology

    by daninfw04 Jan 21, 2014 6:05 PM
    jaketristen jaketristen Jan 22, 2014 12:43 AM Flag

    Thank you Dan. I will look for your future posts.

  • Reply to

    Apology

    by daninfw04 Jan 21, 2014 6:05 PM
    jaketristen jaketristen Jan 21, 2014 8:04 PM Flag

    Great call Dan. Your advice and information has been spot on. You made me a lot of money. It is nice when you have somebody with intelligence posting reliable information. It allowed me to make a better decisions in this sector. LIn, SBGI, GTN, and BLC all made me between 100-200%. Please let us know in June or July what you plan on doing with this sector. Do you have any current stocks you are considering trading? I am still holding a little RAD and large amount HZNP.

RRD
17.76+0.25(+1.43%)Apr 17 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.